Bio-reference Labs, Inc. (BRLI) Misses Q1 EPS by 8c (Earlier)
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/30/2026
- Wall Street ends lower as Alphabet revenue miss revives AI capex jitters
- Alphabet shares tumble 10% as earnings miss overshadows cloud boom
- Microsoft rises premarket as cloud strength drives earnings beat
- Caterpillar shares slump 10% despite earnings beat amid rapid AI buildout
- DoorDash to acquire Instacart in $17 billion deal
Tweet
Share
E-mailGet Alerts BRLI Hot Sheet
Join SI Premium – FREE
Bio-reference Labs, Inc. (NASDAQ: BRLI) reported Q1 EPS of $0.24, $0.08 worse than the analyst estimate of $0.32. Revenue for the quarter came in at $209 million versus the consensus estimate of $216.4 million. Bio-reference Labs, Inc. reaffirmed FY2015 guidance.
For earnings history and earnings-related data on Bio-reference Labs, Inc. (BRLI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- SPS Commerce (SPSC) Tops Q3 EPS by 16c; Offers Guidance
- FTI Consulting (FCN) Tops Q3 EPS by 110c; offers guidance
- Methanex (MEOH) Tops Q3 EPS by 87c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
